Enhertu 100mg (Trastuzumab deruxtecan Vials) 100mg

Enhertu 100mg is a prescription medication containing trastuzumab deruxtecan, available as single-use vials for intravenous use. This targeted therapy is used in oncology settings for specific cancer treatments. Store between 2-8°C to maintain potency.

Strength

100mg

Pack Size

Storage

2-8°

Manufacturer / TM Owner

Baxter Oncology Gmbh

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Trastuzumab deruxtecan is primarily used in cancer treatment, particularly for HER2-positive breast cancer and other HER2-expressing malignancies. It may be prescribed when standard therapies are ineffective or unsuitable. The medication works by targeting cancer cells with specific proteins. Patients often ask what is trastuzumab deruxtecan used for to understand its role in treatment plans.

Side Effects

This medication works by delivering chemotherapy directly to cancer cells while sparing healthy tissue. Common effects include temporary changes in blood cell counts, which may affect energy levels. Some patients experience mild gastrointestinal effects during treatment. These responses vary widely between individuals.

Precautions & Warnings

Always handle vials with care to prevent contamination or breakage. Keep medication refrigerated between 2-8°C and protect from light. Do not freeze or shake the vials. Use within specified timeframes after preparation. Follow healthcare provider instructions for proper disposal of used materials.

Avoid Interactions

This medication may interact with other drugs that affect heart function or blood cell production. Certain chemotherapy agents or radiation therapy might be used alongside it. Always inform healthcare providers about all medications being taken. Some herbal supplements or over-the-counter products could potentially interact.

Frequently Asked Questions

It is used to treat certain types of HER2-positive cancers, including breast cancer.

It is given as an intravenous infusion by healthcare professionals in a clinical setting.

Common effects may include changes in blood counts, nausea, or fatigue.

No, it must be refrigerated between 2-8°C and protected from light.

Yes, it is a targeted chemotherapy medication that affects specific cancer cells.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.